1Chalmers J,MacMahon S,Mancia G,et al.1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension.Guidelines sub-committee of the World Health Organization[J].Clin Exp Hypertens,1999,21 (5-6):1 009-1 060. 被引量：1
6Velussi M,Brocco E,Frigato F,et al.Effects of cilazapril and amlodipin on kidney function in hypertensive NIDDM patients[J].Diabetes,1996,45(3):216-222. 被引量：1
2[1]Devereux RB,Alonso DR.Lutas EM,et al.Echocardiogrphic assessment of left Ventricular hypertrophg:Comparison to necropsy finding[J].Am J Cardiol,19 86,57∶450. 被引量：1
3[2]Levy D,Garrison RJ,Savage DD,et al.Prognostic implications of echoca rdiographically determined left ventricular mass in the Eramingham heart study[ J].N Emgl J Med,1990,312∶1561. 被引量：1
4[3]Edwak DD,Frohlich Facc.Left Ventricular hypertrophy,Cardial diseases and hypertension:Recent experience[J].J Am Coll Cardial,1989,14∶1587. 被引量：1
5Croom KF, Curran MP, Goa KL. Irbesartan: A Review of its Use in Hypertension and in the Management of Diabetic Nephropathy[J]. Drugs, 2004, 64: 999-1028. 被引量：1
6Gashti CN, Bakris GL. The role of calcium antagonists in chronic kidney disease[J]. Nephrology and hypertension,2004,13: 155-161. 被引量：1
7Huan Gui,Yong‐Fei Guo,Xia Liu,Jing‐Ming Zhang,Yan‐Ling Yang,Gao‐Zhong Huang,Jian‐Guo Liu.Effects of Combination Therapy with Levamlodipine and Bisoprolol on Stroke in Rats[J].CNS Neurosci Ther.2013(3) 被引量：1
8Zuojia Liu,Xiliang Zheng,Xiurong Yang,Erkang Wang,Jin Wang.Affinity and Specificity of Levamlodipine-Human Serum Albumin Interactions: Insights into Its Carrier Function[J].Biophysical Journal.2009(10) 被引量：1
